Welcome to Medications.com

Earnings Preview: Bristol-Myers Squibb - Forbes

"Growth from Plavix should be bolstered by income from Abilify (schizophrenia) and Reyataz (HIV infection), but the loss of Pravachol exclusivity will ...

http://www.forbes.com/feeds/ap/20... | Posted: Tue Jan 29 13:46:54 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea